Biblio

Export 1191 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
K. Deniz, Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T. P., Crook, J. E., Lucas, J. A., Graff-Radford, N. R., Carrasquillo, M. M., and Ertekin-Taner, N., “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
K. E. Peters, Davis, W. A., Taddei, K., Martins, R. N., Masters, C. L., Davis, T. M. E., and Bruce, D. G., “Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1127-1133, 2017.
K. E. Peters, Davis, W. A., Taddei, K., Martins, R. N., Masters, C. L., Davis, T. M. E., and Bruce, D. G., “Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1127-1133, 2017.
E. S. Brook, D'Alonzo, Z. J., Lam, V., Chan, D., Dhaliwal, S. Singh, Watts, G. F., Mamo, J. C. L., and Takechi, R., “Plasma Amyloid-β Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.”, J Alzheimers Dis, vol. 93, no. 2, pp. 653-664, 2023.
E. S. Brook, D'Alonzo, Z. J., Lam, V., Chan, D., Dhaliwal, S. Singh, Watts, G. F., Mamo, J. C. L., and Takechi, R., “Plasma Amyloid-β Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.”, J Alzheimers Dis, vol. 93, no. 2, pp. 653-664, 2023.
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.”, J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
L. Lu, Jia, H., Gao, G., Duan, C., Ren, J., Li, Y., and Yang, H., “Pink1 Regulates Tyrosine Hydroxylase Expression and Dopamine Synthesis.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1361-1371, 2018.
F. Du, Yu, Q., and Yan, S. ShiDu, “PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1749-1761, 2021.
N. Bartolotti, Disouky, A., Kalinski, A., Elmann, A., and Lazarov, O., “Phytochemicals from Achillea fragrantissima are Modulators of AβPP Metabolism.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1425-1435, 2018.
G. Ben-Sadoun, Sacco, G., Manera, V., Bourgeois, J., König, A., Foulon, P., Fosty, B., Bremond, F., d'Arripe-Longueville, F., and Robert, P., “Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1299-314, 2016.
P. Siddarth, Rahi, B., Emerson, N. D., Burggren, A. C., Miller, K. J., Bookheimer, S., Lavretsky, H., Dobkin, B., Small, G., and Merrill, D. A., “Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1089-1096, 2018.
A. Antón-Fernández, Merchán-Rubira, J., Avila, J., Hernández, F., DeFelipe, J., and Muñoz, A., “Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 60, no. 2, pp. 651-661, 2017.
M. Zyśk, Bielarczyk, H., Gul-Hinc, S., Dyś, A., Gapys, B., Ronowska, A., Sakowicz-Burkiewicz, M., and Szutowicz, A., “Phenotype-Dependent Interactions between N-acetyl-L-Aspartate and Acetyl-CoA in Septal SN56 Cholinergic Cells Exposed to an Excess of Zinc.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1145-1158, 2017.
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J., “A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
A. M. Lozano, Fosdick, L., M Chakravarty, M., Leoutsakos, J. - M., Munro, C., Oh, E., Drake, K. E., Lyman, C. H., Rosenberg, P. B., Anderson, W. S., Tang-Wai, D. F., Pendergrass, J. Cara, Salloway, S., Asaad, W. F., Ponce, F. A., Burke, A., Sabbagh, M., Wolk, D. A., Baltuch, G., Okun, M. S., Foote, K. D., McAndrews, M. Pat, Giacobbe, P., Targum, S. D., Lyketsos, C. G., and Smith, G. S., “A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 777-87, 2016.
M. Brody, Liu, E., Di, J., Lu, M., Margolin, R. A., Werth, J. L., Booth, K., Shadman, A., H Brashear, R., and Novak, G., “A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1509-1519, 2016.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., “Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
I. Koychev, Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B., Sahakian, B. J., Rowe, J. B., Thomas, A., Rochester, L., Ffytche, D., Howard, R., Zetterberg, H., MacKay, C., and Lovestone, S., “PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
M. S. Rafii, Lukic, A. S., Andrews, R. D., Brewer, J., Rissman, R. A., Strother, S. C., Wernick, M. N., Pennington, C., Mobley, W. C., Ness, S., and Matthews, D. C., “PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).”, J Alzheimers Dis, vol. 60, no. 2, pp. 439-450, 2017.
R. Milne, Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., Georges, J., Fauria, K., Molinuevo, J. - L., Wells, K., Ritchie, C., and Brayne, C., “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
I. Rouch, Pongan, E., Leveque, Y., Tillmann, B., Trombert, B., Getenet, J. Claude, Auguste, N., Krolak-Salmon, P., Laurent, B., and Dorey, J. - M., “Personality Modulates the Efficacy of Art Intervention on Chronic Pain in a Population of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 617-624, 2018.
C. L. Parham, Shaw, C., Auckland, L. D., S Dickeson, K., Griswold-Prenner, I., and Bix, G., “Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1629-1647, 2016.
O. Laugisch, Johnen, A., Maldonado, A., Ehmke, B., Bürgin, W., Olsen, I., Potempa, J., Sculean, A., Duning, T., and Eick, S., “Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 105-114, 2018.
J. Benito-León, Contador, I., Mitchell, A. J., Domingo-Santos, Á., and Bermejo-Pareja, F., “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.

Pages